APA (7th ed.) Citation

Aya Ahmed, Hany M Elsadek, Sally M Shalaby, & Hanan M Elnahas. (2023). Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Aya Ahmed, Hany M Elsadek, Sally M Shalaby, and Hanan M Elnahas. Association of SLC22A1, SLC47A1, and KCNJ11 Polymorphisms with Efficacy and Safety of Metformin and Sulfonylurea Combination Therapy in Egyptian Patients with Type 2 Diabetes. Wolters Kluwer Medknow Publications, 2023.

MLA (9th ed.) Citation

Aya Ahmed, et al. Association of SLC22A1, SLC47A1, and KCNJ11 Polymorphisms with Efficacy and Safety of Metformin and Sulfonylurea Combination Therapy in Egyptian Patients with Type 2 Diabetes. Wolters Kluwer Medknow Publications, 2023.